A group of 17 members of the George Washington University Milken Institute School of Public Health’s (GW Milken Institute SPH) faculty and staff submitted comments on July 26 in response to a recent rule proposed by the U.S. Department of Health and Human Services (HHS). The GW Milken Institute SPH group said they are “deeply concerned about any proposed changes to Title X policies that could adversely impact health center participation, given Title X’s major role in strengthening and enhancing health centers’ family planning performance.”
Impact of Supreme Court Ruling on Arkansas Law Blocking Medication Induced Abortions on Women
Yesterday’s decision by the U.S. Supreme Court not to hear a challenge to a controversial Arkansas law that blocks medication-induced abortions cleared the way for that law to go into effect.
State Medicaid Programs’ Coverage for Long-Acting Reversible Contraception is Uneven, Study Finds
State Medicaid programs must cover family planning services, but wide variation in specific policies around payment and training means low-income women's access to some of the most effective methods of contraception can vary by state. Researchers who analyzed nine states' Medicaid policies around long-acting reversible contraceptives (LARC) found most did not explicitly cover all key elements of quality contraceptive care.
A Case for Continuing to Fund Title X
“Title X family planning clinics play a critical role in ensuring access to a broad range of family planning and preventive health services,” according to the Department of Health and Human Services website. HHS administers the program, which was created in the 1970s with bi-partisan supported and signed into law by President Richard Nixon.